Epilepsy trials recruiting in Virginia

All Epilepsy trials nationally

Cities in Virginia

Recruiting trials in Virginia

• A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
  NCT06872125 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · Virginia: Charlottesville
• A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
  NCT06422923 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Virginia: Charlottesville
• A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy
  NCT06388707 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Charlottesville
• A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
  NCT06132893 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Virginia: Charlottesville, Richmond, Roanoke
• A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
  NCT05667142 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Virginia: Virginia Beach
• Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
  NCT05219617 · Phase: Phase 3 · Ages: 4 Years to 55 Years · Sex: All (male and female) · Virginia: Winchester
• Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
  NCT07563881 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Virginia: Richmond